Abstract
Clinically used valve prostheses are still associated with several limitations. The biological prostheses are limited due to their durability and mechanical valves need permanent oral anticoagulation. Tissue engineering could become a capable tool to create an „ideal” living heart valve with the potential to grow. This would be a matter of particular interest especially in paediatric patients. This article gives a short overview about current concepts, used cell types and clinical experiences with tissue engineered heart valves.
Literatur
-
1
Gummert J F, Funkat A, Beckmann A. et al .
Cardiac surgery in Germany during 2006: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery.
The Thoracic and cardiovascular surgeon.
2007;
55
343-350
-
2
Hoerstrup S P, Sodian R, Daebritz S. et al .
Functional living trileaflet heart valves grown in vitro.
Circulation.
2000;
102
III-44-III-49
-
3
Hilbert S L, Yanagida R, Souza J. et al .
Prototype anionic detergent technique used to decellularize allograft valve conduits evaluated in the right ventricular outflow tract in sheep.
The Journal of heart valve disease.
2004;
13
831-840
-
4
Mendelson K, Schoen F J.
Heart valve tissue engineering: concepts, approaches, progress, and challenges.
Annals of biomedical engineering.
2006;
34
1799-1819
-
5
Schmidt D, Mol A, Breymann C. et al .
Living autologous heart valves engineered from human prenatally harvested progenitors.
Circulation.
2006;
114
I125-131
-
6
Sutherland F W, Perry T E, Sherwood M C. et al .
From stem cells to viable autologous semilunar heart valve.
Circulation.
2005;
111
2783-2791
-
7
Teebken O E, Wilhelmi M, Haverich A.
Tissue engineering for heart valves and vascular grafts.
Der Chirurg.
2005;
76
453-466
-
8
Rabkin-Aikawa E, Farber M, Aikawa M, Schoen F J.
Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves.
The Journal of heart valve disease.
2004;
13
841-847
-
9
Schmidt D, Hoerstrup S P.
Tissue engineered heart valves based on human cells.
Swiss Med Wkly.
2006;
136
618-623
-
10
Schnell A M, Hoerstrup S P, Zund G. et al .
Optimal cell source for cardiovascular tissue engineering: venous vs. aortic human myofibroblasts.
The Thoracic and cardiovascular surgeon.
2001;
49
221-225
-
11
Schmidt D, Mol A, Odermatt B. et al .
Engineering of biologically active living heart valve leaflets using human umbilical cord-derived progenitor cells.
Tissue engineering.
2006;
12
3223-3232
-
12
Hoerstrup S P, Kadner A, Melnitchouk S. et al .
Tissue engineering of functional trileaflet heart valves from human marrow stromal cells.
Circulation.
2002;
106
I143-150
-
13
Perry T E, Kaushal S, Sutherland F WH. et al .
Bone marrow as a cell source for tissue engineering heart valves.
Ann Thorac Surg.
2003;
75
761-767
-
14
Schmidt D, Achermann J, Odermatt B. et al .
Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source.
Circulation.
2007;
116
I64-I70
-
15
Shinoka T, Ma P X, Shum-Tim D. et al .
Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model.
Circulation.
1996;
94
II-164-II-168
-
16
Sodian R, Hoerstrup S P, Sperling J S. et al .
Early in vivo experience with tissue-engineered trileaflet heart valves.
Circulation.
2000;
102
III-22-III-29
-
17
Steinhoff G, Stock U, Karim N. et al .
Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue.
Circulation.
2000;
102
III-50-III-55
-
18
Elkins R C, Dawson P E, Goldstein S, Walsh S P, Black K S.
Decellularized human valve allografts.
Ann Thorac Surg.
2001;
71
S428-S432
-
19
Dohmen P M, Lembcke A, Holinski S. et al .
Mid-term clinical results using a tissue-engineered pulmonary valve to reconstruct the right ventricular outflow tract during the Ross procedure.
Ann Thorac Surg.
2007;
84
729-736
-
20
Dohmen P M, Lembcke A, Hotz H, Kivelitz D, Konertz W.
Ross Operation With a Tissue-Engineered Heart Valve.
Ann Thorac Surg.
2002;
74
1438-1442
-
21
Simon P, Kasimir M T, Seebacher G. et al .
Early failure of the tissue engineered porcine haert valve SYNERGRAFT in pediatric patients.
Eur J Cardiothorac Surg.
2003;
23
1002-1006
Dr. med. Markus Krane
Deutsches Herzzentrum München
Klinik für Herz- und Gefäßchirurgie
Lazarettstr. 36
80636 München
eMail: krane@dhm.mhn.de
